Researchers have been experimenting with mRNA for decades as a potential weapon against cancer, but they haven’t had much luck — until now. In a new study, scientists tested two groups of melanoma patients. They found nearly 79% of patients had no recurrence after 18 months when given a personalized mRNA treatment in addition to the immunotherapy treatment Keytruda. That number was just over 62% for those who only received the immunotherapy. Dr. Ryan Sullivan, associate director of the melanoma program at Mass General Hospital Cancer Center and a co-author of this new study, joined CBS News to talk about it.
View CBS News In
Be the first to know
Get browser notifications for breaking news, live events, and exclusive reporting.
Waco marks 30 years since Branch Davidian siege – CBS News Watch CBS News Wednesday marks three decades since the burning of the Branch Davidian compound in Waco, Texas, that left more than 80 people dead — including dozens of children. Global Project Against Hate and Extremism co-founder Heidi Beirich […]
